Training Seminars

Monday August 13 and Tuesday August 14
Day One 1:00 – 5:00 pm Day Two 8:00 am – 5:00 pm

Introduction to Working with CROs, CDMOs, and CMOs


Ben Locwin, PhD, MBA, Contract Operations Strategic Consultant, Valeocon; Former Senior Leadership Team member, Lonza BioPharma & Biogen

There has been a rise in the securing of external vendors for contract research work (CROs), development & manufacturing (CDMOs), and manufacturing specifically (CMOs) over the past 20 years in the biopharma industry. While initially, these relationships were to provide sources of expertise or scaling that may not have existed at the sponsor organizations, they have quickly become de rigueur to be competitive and successful in the space. These contract organizations provide avenues to access some of the top experts in the various fields of the industry as well as defer and offset risks inherent in the developability, scale-up, and manufacturing for clinical and commercial drug products.

Topics include:

  • Correctly identify CROs, CDMOs, and CMOs
  • Properly understand the various benefits (+) and potential risks (-) inherent with either using contract organizations, or choosing not to use contract organizations
  • Identify the major competitors in the Contract X Organization (CRO, CDMO, CMO) landscape
  • Experience a data-rich lecture on the various specific regulatory issues faced by CXOs, compared with how regulatory perspectives and findings differ in focus for sponsor organizations
  • Learn about the best practice methods for vendor oversight and management for sponsor organizations to properly partner with CXOs
  • Learn how vendor and supplier approaches can make or break the partnership relationships (as well as your portfolio) – and how to take advantage of this knowledge

Instructor Biography:

Ben_LocwinBen Locwin, PhD, MBA, Contract Operations Strategic Consultant, Valeocon; Former Senior Leadership Team member, Lonza BioPharma & Biogen

Ben Locwin has worked in the biotech and pharma industries for 21 years, including over 15 years with CROs, CDMOs, and CMOs, both on the vendor side as well as on the sponsor organization side. He is an expert at developing portfolios and vendor relationships, as well as constructing vendor strategies to defend during regulatory inspections (FDA, MHRA, EMA, PMDA, etc.). He is an in-demand facilitator and speaker for top biopharma organizations, and is a bestselling author in areas of quality, compliance, drug development, and risk management. He has been featured in industry publications as a top voice for many of pharma’s future developments, and has been interviewed for Forbes, The Wall Street Journal, USA Today, The Associated Press, and other media companies.

Training Seminar Information:

Each CHI Training Seminar offers 1.5 days of instruction with start and stop times for each day shown above and on the Event-at-a-Glance published in the onsite Program & Event Guide. Training Seminars will include morning and afternoon refreshment breaks, as applicable, and lunch will be provided to all registered attendees on the full day of the class.

Each person registered specifically for the training seminar will be provided with a hard copy handbook for the seminar in which they are registered. A limited number of additional handbooks will be available for other delegates who wish to attend the seminar, but after these have been distributed, no additional books will be available.

Though CHI encourages track hopping between conference programs, we ask that Training Seminars not be disturbed once they have begun. In the interest of maintaining the highest quality learning environment for Training Seminar attendees, and because Seminars are conducted differently than conference programming, we ask that attendees commit to attending the entire program, and not engage in track hopping, as to not disturb the hands-on style instruction being offered to the other participants.



Premier Sponsors:


Millipore Sigma

Unchained Labs